First AD

Second AD

Key Takeaways and Future Directions in CSU Care

Video content above is prompted by the following:

What advice do you have for dermatologists for managing CSU based on your experience and the data available?

Evolving Perspectives and Treatment Strategies in Chronic Spontaneous Urticaria 

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Peer Exchange

Chronic spontaneous urticaria (CSU) management requires a comprehensive approach, integrating both clinical experience and current data. Dermatologists should prioritize patient education, emphasizing the importance of adherence to treatment plans and lifestyle modifications. First-line treatment typically involves non-sedating H1-antihistamines, with dosage adjustments based on patient response. For refractory cases, omalizumab or cyclosporine may be considered. Regular follow-ups are crucial to monitor treatment efficacy and adjust strategies as needed. Collaboration with allergists or immunologists can enhance patient outcomes, especially in complex cases.

Panelists discuss their advice for dermatologists managing chronic spontaneous urticaria (CSU), emphasizing the importance of individualized treatment plans, and staying updated on emerging therapies and clinical guidelines.

Bringing CSU Back Under The House of Dermatology

Understanding the Chronicity of CSU

The Psychosocial Impact of CSU